AMPLIFY - D6571C00001 Duaklir USA Phase III Study
Public ClinicalTrials.gov record NCT02796677. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 24 Week Treatment, Multicenter, Randomized, Double Blinded, Double Dummy, Parallel-group, Clinical Trial Evaluating the Efficacy and Safety of Aclidinium Bromide 400 μg/Formoterol Fumarate 12 μg Fixed-dose Combination BID Compared With Each Monotherapy (Aclidinium Bromide 400 μg BID and Formoterol Fumarate 12 μg BID) and Tiotropium 18 μg QD When Administered to Patients With Stable Chronic Obstructive Pulmonary Disease.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a multiple dose, randomized, parallel, double-blind, double-dummy, multicenter and multinational Phase III study to determine the efficacy and safety of Aclidinium bromide 400μg/Formoterol Fumarate (AB/FF) 12 μg compared to individual components and TIO (Tiotropium) 18 μg when administered to patients with stable chronic obstructive pulmonary disease (COPD).
Study identification
- NCT ID
- NCT02796677
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,595 participants
Conditions and interventions
Conditions
Interventions
- Aclidinium bromide 400 μg/Formoterol Fumarate 12 μg (AB/FF 400/12 μg) Drug
- Aclidinium bromide 400 μg (AB 400 μg) Drug
- Formoterol fumarate 12 μg (FF 12 μg) Drug
- Placebo to AB/FF 400/12 μg, AB 400 μg and FF 12 μg Other
- Tiotropium 18 μg (TIO 18 μg) Drug
- Placebo to TIO 18 μg Other
Drug · Other
Eligibility (public fields only)
- Age range
- 40 Years to 130 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 5, 2016 (Actual)
- Primary completion
- Jun 8, 2017 (Actual)
- Completion
- Jun 8, 2017 (Actual)
- Last update posted
- Nov 9, 2018
2016 – 2017
United States locations
- U.S. sites
- 85
- U.S. states
- 26
- U.S. cities
- 77
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Gulf Shores | Alabama | 36542 | — |
| Research Site | Phoenix | Arizona | 85018 | — |
| Research Site | Tucson | Arizona | 85712 | — |
| Research Site | Corona | California | 92879 | — |
| Research Site | Fresno | California | 93702 | — |
| Research Site | Fullerton | California | 92835 | — |
| Research Site | Lincoln | California | 95648 | — |
| Research Site | San Diego | California | 92120 | — |
| Research Site | Waterbury | Connecticut | 06708 | — |
| Research Site | Clearwater | Florida | 33765 | — |
| Research Site | Edgewater | Florida | 32132 | — |
| Research Site | Hollywood | Florida | 33021 | — |
| Research Site | Homestead | Florida | 33030 | — |
| Research Site | Miami | Florida | 33144 | — |
| Research Site | Miami | Florida | 33186 | — |
| Research Site | Miami Lakes | Florida | 33016 | — |
| Research Site | Ormond Beach | Florida | 32174 | — |
| Research Site | Port Orange | Florida | 32129 | — |
| Research Site | Sarasota | Florida | 34233 | — |
| Research Site | St. Petersburg | Florida | 33704 | — |
| Research Site | St. Petersburg | Florida | 33709 | — |
| Research Site | Tampa | Florida | 33603 | — |
| Research Site | Winter Park | Florida | 32789 | — |
| Research Site | Blue Ridge | Georgia | 30513 | — |
| Research Site | Woodstock | Georgia | 30189 | — |
| Research Site | Chicago | Illinois | 60602 | — |
| Research Site | Portage | Indiana | 46368 | — |
| Research Site | Lafayette | Louisiana | 70508 | — |
| Research Site | Fall River | Massachusetts | 02720 | — |
| Research Site | Chelsea | Michigan | 48118 | — |
| Research Site | Farmington Hills | Michigan | 48336 | — |
| Research Site | Troy | Michigan | 48085 | — |
| Research Site | Edina | Minnesota | 55435 | — |
| Research Site | Fridley | Minnesota | 55432 | — |
| Research Site | Minneapolis | Minnesota | 55407 | — |
| Research Site | Woodbury | Minnesota | 55125 | — |
| Research Site | Saint Charles | Missouri | 63301 | — |
| Research Site | St Louis | Missouri | 63117 | — |
| Research Site | St Louis | Missouri | 63141 | — |
| Research Site | Fremont | Nebraska | 68025 | — |
| Research Site | Omaha | Nebraska | 68114 | — |
| Research Site | Omaha | Nebraska | 68134 | — |
| Research Site | Las Vegas | Nevada | 89102 | — |
| Research Site | Brooklyn | New York | 11230 | — |
| Research Site | Buffalo | New York | 14215 | — |
| Research Site | New York | New York | 10036 | — |
| Research Site | Rochester | New York | 14618 | — |
| Research Site | The Bronx | New York | 10455 | — |
| Research Site | Charlotte | North Carolina | 28207 | — |
| Research Site | Charlotte | North Carolina | 28277 | — |
| Research Site | Gastonia | North Carolina | 28054 | — |
| Research Site | Wilmington | North Carolina | 28401 | — |
| Research Site | Canton | Ohio | 44718 | — |
| Research Site | Cincinnati | Ohio | 45231 | — |
| Research Site | Cincinnati | Ohio | 45242 | — |
| Research Site | Cincinnati | Ohio | 45246 | — |
| Research Site | Columbus | Ohio | 43207 | — |
| Research Site | Columbus | Ohio | 43215 | — |
| Research Site | Dublin | Ohio | 43016 | — |
| Research Site | Grove City | Ohio | 43123 | — |
| Research Site | Edmond | Oklahoma | 73034 | — |
| Research Site | Midwest City | Oklahoma | 73110 | — |
| Research Site | Oklahoma City | Oklahoma | 73104 | — |
| Research Site | Medford | Oregon | 97504 | — |
| Research Site | Altoona | Pennsylvania | 16602 | — |
| Research Site | Pittsburgh | Pennsylvania | 15243 | — |
| Research Site | Wyomissing | Pennsylvania | 19610 | — |
| Research Site | East Providence | Rhode Island | 02914 | — |
| Research Site | Columbia | South Carolina | 29204 | — |
| Research Site | Gaffney | South Carolina | 29340 | — |
| Research Site | Mt. Pleasant | South Carolina | 29464 | — |
| Research Site | Spartanburg | South Carolina | 29303 | — |
| Research Site | Union | South Carolina | 29379 | — |
| Research Site | Arlington | Texas | 76012 | — |
| Research Site | Baytown | Texas | 77521 | — |
| Research Site | Boerne | Texas | 78006 | — |
| Research Site | Dallas | Texas | 75225 | — |
| Research Site | Fort Worth | Texas | 76104 | — |
| Research Site | Houston | Texas | 77074 | — |
| Research Site | Lewisville | Texas | 75067 | — |
| Research Site | McKinney | Texas | 75069 | — |
| Research Site | Tomball | Texas | 77375 | — |
| Research Site | Midvale | Utah | 84047 | — |
| Research Site | Abingdon | Virginia | 24210 | — |
| Research Site | Newport News | Virginia | 23606 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 78 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02796677, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 9, 2018 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02796677 live on ClinicalTrials.gov.